|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.100 EUR | +0.92% |
|
0.00% | -25.17% |
| 04/06 | Equities trend higher; banks lead gains on the MIB | AN |
| 22/05 | European markets rebound; STM and Stellantis lead gains | AN |
Business description: Laboratorio Farmaceutico Erfo S.p.A.

Number of employees: 50
Sales by Activity: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Network | - | 39.47L | 47.41L | 46.21L | 78.61L |
Direct | 6L | 5L | 7L | 9L | 10.88L |
Other | - | 5L | 6L | 6L | 7L |
Medical | - | 1L | 2L | 3L | 4L |
Revenues from Services | 1.12T | - | - | - | - |
Wholesale Sales Revenues | 40.72L | - | - | - | - |
Geographical breakdown of sales: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
ITALY | 46.63L | 50.13L | 52.28L | 53.29L | 89.59L |
France | - | - | 8L | 9L | 9L |
Belgium | - | - | 2L | 2L | 2L |
Other (EU) | - | - | 5T | - | - |
Spain | 8T | 15.4T | 5.17T | 184 | - |
Executive Committee: Laboratorio Farmaceutico Erfo S.p.A.
| Manager | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CEO | Chief Executive Officer | 55 | 01/01/2013 |
| Director of Finance/CFO | - | - |
Composition of the Board of Directors: Laboratorio Farmaceutico Erfo S.p.A.
| Director | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CHM | Chairman | 55 | 01/01/2013 |
Flavio Corpina
BRD | Director/Board Member | 47 | 01/01/2017 |
Fabio Giuffre
BRD | Director/Board Member | 45 | - |
Company details: Laboratorio Farmaceutico Erfo S.p.A.
Laboratorio Farmaceutico Erfo SpA
Viale Geki Russo, 9
98049, Tirrena
+39 09 09 14 61 25
http://www.erfo.it
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.92% | 0.00% | -8.71% | -6.78% | 1.07Cr | ||
| -2.30% | +0.55% | +40.10% | +155.47% | 1,03500Cr | ||
| +0.86% | +3.42% | +53.66% | +50.55% | 57TCr | ||
| +0.97% | -0.19% | +17.87% | +64.67% | 40TCr | ||
| +0.58% | +0.77% | +21.19% | +15.95% | 32TCr | ||
| -0.85% | -2.86% | +22.05% | +13.80% | 28TCr | ||
| +0.44% | +3.48% | +24.48% | +34.39% | 28TCr | ||
| +1.66% | +5.61% | -44.67% | -47.49% | 19TCr | ||
| -0.05% | +1.24% | +19.04% | +62.82% | 19TCr | ||
| -0.33% | -2.77% | +12.08% | +61.30% | 16TCr | ||
| Average | +0.22% | +1.07% | +15.71% | +40.47% | 34.3TCr | |
| Weighted average by Cap. | -0.32% | +2.39% | +28.04% | +71.92% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ERFO Stock
- Company Laboratorio Farmaceutico Erfo S.p.A.
Select your edition
All financial news and data tailored to specific country editions

















